Difference between revisions of "Part:BBa K4414000"

 
(15 intermediate revisions by 4 users not shown)
Line 4: Line 4:
 
<partinfo>BBa_K4414000 short</partinfo>
 
<partinfo>BBa_K4414000 short</partinfo>
  
This part is the ligand-binding domain (LBD) of the human glucocorticoid receptor (GR)..
+
This part is the ligand-binding domain (LBD) of the human glucocorticoid receptor (GR).
  
 
==Usage and Biology==
 
==Usage and Biology==
  
The human glucocorticoid receptor is encoded by NR3C1 (Nuclear Receptor Subfamily 3, Group C, Member 1) gene. GR functions as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription (Lu & Cidlowski, 2005). In the absence of glucocorticoids, GR binds to small molecular chaperone proteins in the cytoplasm and stays in the cytoplasm. Following glucocorticoid stimulation, it changes its conformation and dissociates from the chaperone protein, thereby exposing the nuclear localization sequence on the ligand-binding domain, which facilitates the entry of the GR into the nucleus.  
+
The human glucocorticoid receptor is encoded by NR3C1 (Nuclear Receptor Subfamily 3, Group C, Member 1) gene. GR functions as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription (Lu & Cidlowski, 2005). In the absence of glucocorticoids, GR binds to small molecular chaperone proteins in the cytoplasm and stays in the cytoplasm. Following glucocorticoid stimulation, it changes its conformation and dissociates from the chaperone protein, thereby exposing the nuclear localization sequence on the ligand-binding domain, which facilitates the entry of the GR into the nucleus. GR consists of an N-terminus binding domain (NTD), a DNA binding domain (DBD), and a ligand binding domain (LBD). As the major functional domain, the LBD domain is responsible for sensing glucocorticoid signals and translocating the protein into the nucleus (Monsalve et al., 2019). It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression (Weikum et al., 2017). We obtained this DNA by PCR amplification from human cDNA.This part can be used in level 1 biological laboratory.
GR consists of an N-terminus binding domain (NTD), a DNA binding domain (DBD), and a ligand binding domain (LBD). As the major functional domain, the LBD domain is responsible for sensing glucocorticoid signals and translocating the protein into the nucleus (Monsalve et al., 2019). It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression (Weikum et al., 2017).  
+
 
+
  
 
<html>
 
<html>
  
 
<figure class="figure">
 
<figure class="figure">
<img src="https://static.igem.wiki/teams/4414/wiki/00-1.png" class="figure-img img-fluid rounded"  height="200px">
+
<img src="https://static.igem.wiki/teams/4414/wiki/000.png" class="figure-img img-fluid rounded"  height="400px">
  
 
</figure>
 
</figure>
Line 22: Line 20:
 
Figure1: Linear domain structure of glucocorticoid receptor (GR) (Weikum et al., 2017)
 
Figure1: Linear domain structure of glucocorticoid receptor (GR) (Weikum et al., 2017)
  
===Sequecing===
 
The plasmid was sequenced correct.
 
  
  
Line 43: Line 39:
  
 
<figure class="figure">
 
<figure class="figure">
<img src="https://static.igem.wiki/teams/4414/wiki/00-2.png" class="figure-img img-fluid rounded"  height="250px">
+
<img src="https://static.igem.wiki/teams/4414/wiki/00-2.png" class="figure-img img-fluid rounded"  height="350px">
  
 
</figure>
 
</figure>
Line 49: Line 45:
 
</html>
 
</html>
  
Figure2: LBD can enter the nucleus in response to the stimulation of glucocorticoid
+
Figure2: EGFP-labeled GR<sub>LBD</sub> localization in HEK-293T cells w/wo glucocorticoid stimulation. For wide-field microscopy, cells were transfected with pNC051 (P<sub>CMV</sub>-GR<sub>LBD</sub>-EGFP). For confocal images, cells were co-transfected with F-actin labeling pXQ100 (P<sub>CMV</sub>-lifeact-mcherry) and GR<sub>LBD</sub> labeling pNC051 (P<sub>CMV</sub>-GR<sub>LBD</sub>-EGFP). Photos were taken 48 h post-DMEM or glucocorticoid administration, scale bar: 100 µm for wide-field microscopy and 10 µm for confocal microscopy. Data are representative images of 3 independent experiments.
For validation of LBD transcriptional activation capabilities, please refer to our registered composite element (BBa_K4414024), which we used TETR to fill the DBD section and found that LBD can activate the expression of downstream genes.
+
  
  
 
===Reference===
 
===Reference===
[1].Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174. doi: 10.1038/nrm.2016.152. Epub 2017 Jan 5. PMID: 28053348; PMCID: PMC6257982.
+
1.Lu, N. Z., & Cidlowski, J. A. (2005). Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Molecular Cell, 18(3), 331–342. https://doi.org/10.1016/j.molcel.2005.03.025
 +
 
 +
2.Monsalve, G. C., Yamamoto, K. R., & Ward, J. D. (2019). A New Tool for Inducible Gene Expression in Caenorhabditis elegans. Genetics, 211(2), 419–430. https://doi.org/10.1534/genetics.118.301705
 +
 
 +
3.Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: Precision and plasticity via allostery. Nature Reviews. Molecular Cell Biology, 18(3), 159–174. https://doi.org/10.1038/nrm.2016.152

Latest revision as of 03:44, 14 October 2022


Ligand-binding domain (LBD) of NR3C1

This part is the ligand-binding domain (LBD) of the human glucocorticoid receptor (GR).

Usage and Biology

The human glucocorticoid receptor is encoded by NR3C1 (Nuclear Receptor Subfamily 3, Group C, Member 1) gene. GR functions as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription (Lu & Cidlowski, 2005). In the absence of glucocorticoids, GR binds to small molecular chaperone proteins in the cytoplasm and stays in the cytoplasm. Following glucocorticoid stimulation, it changes its conformation and dissociates from the chaperone protein, thereby exposing the nuclear localization sequence on the ligand-binding domain, which facilitates the entry of the GR into the nucleus. GR consists of an N-terminus binding domain (NTD), a DNA binding domain (DBD), and a ligand binding domain (LBD). As the major functional domain, the LBD domain is responsible for sensing glucocorticoid signals and translocating the protein into the nucleus (Monsalve et al., 2019). It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression (Weikum et al., 2017). We obtained this DNA by PCR amplification from human cDNA.This part can be used in level 1 biological laboratory.

Figure1: Linear domain structure of glucocorticoid receptor (GR) (Weikum et al., 2017)


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]



Functional characterization and result

We constructed a plasmid that linked LBD to the fluorescent protein EGFP to verify the function of LBD. Cells are treated with 500 and 1000 nM glucocorticoids 6 h after transfection of plasmids into HEK-293T cells. Cells without glucocorticoid treatment were used as control. The results showed that glucocorticoid-treated cells fluorescence was mainly present in the nucleus compared to non-treated control, suggesting that glucocorticoids can bind to LBD and enter the nucleus.

Figure2: EGFP-labeled GRLBD localization in HEK-293T cells w/wo glucocorticoid stimulation. For wide-field microscopy, cells were transfected with pNC051 (PCMV-GRLBD-EGFP). For confocal images, cells were co-transfected with F-actin labeling pXQ100 (PCMV-lifeact-mcherry) and GRLBD labeling pNC051 (PCMV-GRLBD-EGFP). Photos were taken 48 h post-DMEM or glucocorticoid administration, scale bar: 100 µm for wide-field microscopy and 10 µm for confocal microscopy. Data are representative images of 3 independent experiments.


Reference

1.Lu, N. Z., & Cidlowski, J. A. (2005). Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Molecular Cell, 18(3), 331–342. https://doi.org/10.1016/j.molcel.2005.03.025

2.Monsalve, G. C., Yamamoto, K. R., & Ward, J. D. (2019). A New Tool for Inducible Gene Expression in Caenorhabditis elegans. Genetics, 211(2), 419–430. https://doi.org/10.1534/genetics.118.301705

3.Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: Precision and plasticity via allostery. Nature Reviews. Molecular Cell Biology, 18(3), 159–174. https://doi.org/10.1038/nrm.2016.152